Baker McKenzie advised VINCI Energies S.A. on the acquisition of significant parts of the IT services business of Kontron AG. The transaction includes the business in Germany, Switzerland, Poland and eight other countries in Central and Eastern Europe with revenues of EUR 360 million and 1,600 employees. The purchase is subject to approval by the relevant antitrust authorities.
"We are proud that our colleagues successfully worked across borders with the VINCI Energies S.A. team to best achieve the client's objectives," commented Peter Wand, lead partner on the transaction.
With this acquisition, VINCI Energies S.A. - through its Axians brand active in this field - strengthens its position in the European information and communication technology market. Vinci Energies S.A. is a global group with EUR 15.1 billion in sales in 2021 and 85,700 employees in 57 countries, part of the listed French infrastructure group VINCI S.A..
The technology group Kontron AG (formerly S&T AG) has a global presence with more than 6,000 employees and subsidiaries in 32 countries. Listed on the TecDAX and SDAX of the German Stock Exchange, the company is a leading provider of smart solutions for a wide range of industries.
Most recently, Baker McKenzie advised FUNKE Digital on the acquisition of Baseplus DIGITAL MEDIA GmbH, Knorr-Bremse AG on the sale of its 9.2% stake in the listed Swedish company Haldex AB to SAF-Holland S, Siemens on the sale of its Commercial Vehicles business to Meritor, Andera Partners, Evotec and Fund+ on a EUR 60 million Series B financing of Tubulis GmbH, Allecra Therapeutics on an exclusive license and supply agreement with ADVANZ PHARMA, MODAG on a strategic collaboration with Teva, Chord Therapeutics on its sale to Merck KGaA, LSP as lead investor on a EUR 20 million Series A Equity Financing in Innovative Molecules, Numab Therapeutics on a CHF 100 million Cross Over Financing, CatalYm on a EUR 50 million Series B financing led by Vesalius Capital, Casdin Capital on a USD 50 million extension of the Series B Equity Financing in DNA Script, and Chr. Hansen Holding on the acquisition of Jennewein Biotechnologie.
Legal advisor to Vinci:
Baker McKenzie
Lead:
Corporate/M&A: Peter Wand (partner, Frankfurt)
Team:
Corporate/M&A: Denise Tayler (associate, Frankfurt), Gerhard Hermann (partner, Vienna), Claudia-Fochtmann-Tischler (counsel, Vienna), Edmund Schuster (counsel, Vienna), Mariella Neidhardt (associate, Vienna), Teresa Stüttler (associate, Vienna)
Tax: Stephan Behnes (principal counsel, Frankfurt), Philipp Stanek (counsel, Vienna)
Antitrust: Jonas Brueckner (counsel, Berlin), Nicolas Kredel (partner, Dusseldorf), Florian Kotman (associate, Dusseldorf), Ricarda Brandhorst (associate, Dusseldorf)
Commercial & Trade: Johannes Teichmann (partner, Frankfurt), Joachim Fröhlich (counsel, Munich), Daniel Larcher (associate, Vienna), Abanoub Abd El Malak (associate, Vienna)
Employment: Gregor Dornbusch (partner, Frankfurt), Agnes Herwig (senior associate, Frankfurt), Anna Lehner (associate, Frankfurt), Andrea Haiden (associate, Vienna)
IP: Markus Hecht (counsel, Frankfurt), Anela Kapetanidis (associate, Frankfurt), Martina Grama (associate, Vienna)
IT: Holger Lutz (partner, Frankfurt), Simone Rieken (partner, Frankfurt), Tobias Born (senior associate, Frankfurt), Andreas Jagusch (associate, Frankfurt), Adrian Brandauer (associate, Vienna), Silvia Grohmann (associate, Vienna)
Public Law: Katharina Weiner (counsel, Dusseldorf)
Real Estate: Till Pflug (associate, Frankfurt), Jeneka Manoharan (associate, Frankfurt), Wolfgang Eigner (counsel, Vienna), Filip Peric (associate, Vienna) as well as further Baker McKenzie attorneys in other offices.